Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2024-03-27 M&A Activity
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권취득결정(자율공시)
M&A Activity Classification · 95% confidence The document is a regulatory filing from the Korean stock market (DART system) regarding a 'Decision to Acquire Shares and Securities of Another Corporation' (타법인주식및출자증권취득결정). It is a formal disclosure of a corporate investment activity (establishing a subsidiary in Japan). Since it does not fit into specific categories like M&A (which usually implies buying an existing business/merger) or capital changes (like share issuance), and it is a standard regulatory disclosure of a corporate action, it falls under the 'Regulatory Filings' (RNS) category.
2024-03-27 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Cytogen regarding the 'Results of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds. It details the issuance amount, payment date, and confirms the completion of the transaction. This falls under the category of capital and financing updates.
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by CytoGen. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a regulatory disclosure announcement (a 'menu' item) confirming the submission of the audit report to the exchange, rather than the full, multi-page audit report document itself. Therefore, it is classified as a Report Publication Announcement. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the 14th fiscal year (2023) of Cytogen. It contains detailed financial data, management discussion, business overview, and corporate governance information. In the context of Korean regulatory filings (DART), this is the equivalent of an Annual Report (10-K). FY 2023
2024-03-20 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and includes a correction (정정신고) to the initial filing. In the context of Korean corporate filings (DART system), this type of document detailing capital structure changes, specifically the issuance of convertible bonds, falls under the 'Capital/Financing Update' category.
2024-03-19 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by CytoGen. It details the terms of the financing, including interest rates, conversion prices, put/call options, and the use of proceeds. This falls under the category of company fundraising and capital structure changes.
2024-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.